share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 7 06:41
Summary by Futu AI
Recursion Pharmaceuticals, Inc. officer and director, Gibson Christopher, is set to sell 25,000 Class A shares on 03/06/2024, as per the latest SEC filing. The shares, valued at an aggregate market value of $288,817.01, were originally acquired as founders shares on 09/01/2016 as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 163,954 shares were sold for gross proceeds of approximately $1.42 million.
Recursion Pharmaceuticals, Inc. officer and director, Gibson Christopher, is set to sell 25,000 Class A shares on 03/06/2024, as per the latest SEC filing. The shares, valued at an aggregate market value of $288,817.01, were originally acquired as founders shares on 09/01/2016 as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 163,954 shares were sold for gross proceeds of approximately $1.42 million.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.